United States — United States Securities and Exchange Commission & LifeSci Capital
12 shared events · Importance 4 · Last updated Aug 07, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
United States — United States Securities and Exchange Commission: The SEC declared the registration statements effective, enabling the IPO to proceed. This regulatory action is routine but essential for the offering's completion.
LifeSci Capital: LifeSci Capital participated as a joint book-running manager, gaining underwriting fees and exposure in the biotech IPO market. The deal contributes to its deal flow and industry standing.
Aug 07, 2026 · 8 articles
Business
United States — United States Securities and Exchange Commission: The SEC declared the registration statement effective, enabling the IPO to proceed, fulfilling its regulatory oversight role.
LifeSci Capital: LifeSci Capital acted as passive book-running manager, participating in the offering and earning associated fees.
Aug 05, 2026 · 15 articles
Business
United States — United States Securities and Exchange Commission: The SEC reviewed and declared effective the registration statements for the IPO, fulfilling its regulatory oversight role in the offering.
LifeSci Capital: LifeSci Capital served as a joint book-running manager, participating in the offering and benefiting from the transaction.
Jul 31, 2026 · 10 articles
Business
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission declared effective Altor BioScience' shelf registration statement on Form S-3, allowing the public offering to proceed.
LifeSci Capital: LifeSci Capital is acting as a passive book-running manager for the public offering by Altor BioScience.
Jun 03, 2026 · 12 articles
Business
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission is the regulatory body with which Enliven Therapeutics filed its registration statement and prospectus supplements for the offering.
LifeSci Capital: LifeSci Capital is acting as a passive book-running manager for the public offering by Enliven Therapeutics.
Jun 11, 2026 · 7 articles
Business
United States — United States Securities and Exchange Commission: Neurogene filed a shelf registration statement with the United States — United States Securities and Exchange Commission, which was declared effective, enabling the public offering.
LifeSci Capital: LifeSci Capital is acting as a joint bookrunning manager for Neurogene's public offering.
Jun 30, 2026 · 6 articles
Business
United States — United States Securities and Exchange Commission: The offering was conducted under an effective shelf registration statement filed with the SEC.
LifeSci Capital: Acted as joint book-running manager, earning underwriting fees.
Jul 21, 2026 · 6 articles
Business
United States — United States Securities and Exchange Commission: The United States — United States Securities and Exchange Commission received registration statements for the offering, ensuring regulatory compliance.
LifeSci Capital: LifeSci Capital LLC is acting as a passive bookrunning manager for the initial public offering of Parabilis Medicines.
Jun 10, 2026 · 7 articles
Business
United States — United States Securities and Exchange Commission: The SEC declared the shelf registration statement effective on July 10, 2026, enabling the offering.
LifeSci Capital: LifeSci Capital acted as passive book-running manager for the offering.
Jul 14, 2026 · 7 articles
Business
LifeSci Capital: LifeSci Capital is acting as a co-lead manager for the public offering by Celldex Therapeutics.
Apr 01, 2026 · 6 articles
Business
LifeSci Capital: LifeSci Capital is acting as a passive bookrunner for the public offering of Spyre Therapeutics' common stock.
Apr 13, 2026 · 7 articles
Business
LifeSci Capital: LifeSci Capital acted as a placement agent in connection with the concurrent private placement financing.
Apr 14, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — United States Securities and Exchange Commission and LifeSci Capital interact across events, view sentiment trends, and discover connected entities.
Open Dashboard